We are live on
!
Find out more
CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.67B
1-Year Est. Return
89%
This Fund
S&P 500
This Quarter
Est. Return
+16%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$324M
AUM Growth
+$28.5M
(+9.6%)
Cap. Flow
-$2.62M
Cap. Flow
% of AUM
-0.81%
Top 10 Holdings %
Top 10 Hldgs %
32.96%
Holding
465
New
18
Increased
159
Reduced
243
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard World Funds Extended Duration ETF
EDV
|
+$3.29M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$1.96M |
| 3 |
Apple
AAPL
|
+$1.92M |
| 4 |
Vaxcyte
PCVX
|
+$1.9M |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.81M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iQIYI
IQ
|
+$5.11M |
| 2 |
Amazon
AMZN
|
+$4.12M |
| 3 |
Airbnb
ABNB
|
+$2.92M |
| 4 |
Analog Devices
ADI
|
+$2.79M |
| 5 |
KE Holdings
BEKE
|
+$2.12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 41.8% |
| 2 | Consumer Discretionary | 21.38% |
| 3 | Healthcare | 19.26% |
| 4 | Communication Services | 6.74% |
| 5 | Financials | 4.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Baker Hughes
BKR
$63.8B
| $36.1K | 0.01% |
1,142
+836
| +273% | +$24.4K |
|
227
Warner Bros
WBD
$69.3B
| $34.5K | 0.01% |
2,749
+2,014
| +274% | +$26.1K |
|
|
MORF
228
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $34.4K | 0.01% |
600
+64
| +12% | +$3.34K |
|
|
AKRO
229
DELISTED
Akero Therapeutics
AKRO
| $33.9K | 0.01% |
725
+91
| +14% | +$4.17K |
|
|
KDNY
230
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $33.7K | 0.01% |
876
-16
| -2% | -$411 |
|
231
Constellation Energy
CEG
$98.7B
| $33.5K | 0.01% |
366
+267
| +270% | +$22.1K |
|
232
Immunovant
IMVT
$8.8B
| $32.4K | 0.01% |
1,709
-55
| -3% | -$1.03K |
|
|
ANSS
233
DELISTED
Ansys
ANSS
| $32.4K | 0.01% |
98
+72
| +277% | +$22.8K |
|
234
Xenon Pharmaceuticals
XENE
$6.31B
| $32.1K | 0.01% |
833
-15
| -2% | -$596 |
|
|
CVAC
235
DELISTED
CureVac
CVAC
| $30.6K | 0.01% |
2,934
-74
| -2% | -$662 |
|
|
DICE
236
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $29.1K | 0.01% |
626
-20
| -3% | -$691 |
|
|
NUVL
237
DELISTED
Nuvalent
NUVL
| $28.4K | 0.01% |
673
-18
| -3% | -$681 |
|
|
RVNC
238
DELISTED
Revance Therapeutics, Inc.
RVNC
| $27.9K | 0.01% |
1,102
-20
| -2% | -$623 |
|
|
WBA
239
DELISTED
Walgreens Boots Alliance
WBA
| $27.7K | 0.01% |
974
+713
| +273% | +$23.2K |
|
240
Harmony Biosciences
HRMY
$2.32B
| $27.6K | 0.01% |
785
-22
| -3% | -$759 |
|
|
MRTX
241
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $27.5K | 0.01% |
762
-24
| -3% | -$989 |
|
242
eBay
EBAY
$45.5B
| $26.9K | 0.01% |
603
+441
| +272% | +$19.6K |
|
243
Diamondback Energy
FANG
$56.2B
| $26.8K | 0.01% |
204
+148
| +264% | +$19.8K |
|
244
Enphase Energy
ENPH
$5.39B
| $26K | 0.01% |
155
+114
| +278% | +$20.4K |
|
|
VTYX
245
DELISTED
Ventyx Biosciences
VTYX
| $25.2K | 0.01% |
767
| – | – |
|
246
Myriad Genetics
MYGN
$309M
| $24.8K | 0.01% |
1,069
-29
| -3% | -$633 |
|
247
Immunocore
IMCR
$1.77B
| $24.6K | 0.01% |
410
+6
| +1% | +$342 |
|
248
AbCellera Biologics
ABCL
$3.18B
| $24.5K | 0.01% |
3,785
-113
| -3% | -$771 |
|
249
JD.com
JD
$42.7B
| $24.3K | 0.01% |
712
+373
| +110% | +$13.6K |
|
250
Veracyte
VCYT
$3.59B
| $24.2K | 0.01% |
949
-23
| -2% | -$558 |
|
Similar funds
HA
JPM
CPO
LCI
GWM
JIP
RMC
GACM
China Universal Asset Management Company's Q2 2023 Portfolio in Review
As of Q2 2023, China Universal Asset Management Company held 465 positions worth $324M, up 9.6% from $295M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
China Universal Asset Management Company's Q2 2023 filing shows 18 new, 159 increased, 243 reduced and 13 closed positions. Its largest new stake was Vanguard World Funds Extended Duration ETF: 37,709 shares worth $3.28M. The largest sale was iQIYI, an estimated $5.11M.
By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 38% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- China Universal Asset Management Company's largest Q2 2023 buy was Vanguard World Funds Extended Duration ETF: 37,709 shares worth $3.28M.
- China Universal Asset Management Company added most to Alnylam Pharmaceuticals in Q2 2023, an estimated $1.96M increase.
- China Universal Asset Management Company's biggest Q2 2023 reduction was iQIYI, cutting an estimated $5.11M.
- China Universal Asset Management Company fully exited Block Inc in Q2 2023, selling an estimated $1.35M.
- China Universal Asset Management Company's ten largest holdings make up 33% of its $324M portfolio in Q2 2023.
- China Universal Asset Management Company opened 18 new positions and closed 13 in Q2 2023.
- China Universal Asset Management Company's portfolio value rose 9.6% quarter-over-quarter to $324M.
Based on China Universal Asset Management Company's 13F filing for Q2 2023, filed 28 Jul 2023.